L-Valine Producing Strain via α-Acetolactate Flux Redirection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing L-valine through microbial fermentation, such as using Corynebacterium glutamicum and Escherichia coli, suffer from low production efficiency and substrate conversion rates, making it difficult to meet industrial requirements.

Innovation Solution

Genetically engineer 2,3-butanediol or acetoin producing strains by inhibiting the synthesis of by-products like acetoin and 2,3-butanediol, and introducing an exogenous L-valine biosynthetic pathway, optimizing L-valine synthetic flux and efflux, and redirecting α-acetolactate metabolic flow to enhance L-valine production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional fermentation methods using C. glutamicum or E. coli are used, then L-valine production is achieved, but production efficiency and substrate conversion rate are low

Engineering Contradiction:
ImproveL-valine production efficiencyVSAvoidfermentation system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent changes key metabolic parameters by introducing heterologous genes (ilvC, ilvD, ilvE, bcd, alsS) to alter the metabolic flux distribution. This redirects carbon flow from the original fermentation pathways toward L-valine synthesis, achieving higher production efficiency (up to 2.14 g/L/h) and substrate conversion rate (up to 0.587 g/g) while maintaining the fermentation system framework

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent segments the metabolic pathway into distinct functional modules: alpha-acetolactate synthesis (alsS), isomeroreduction (ilvC), dehydration (ilvD), and transamination (bcd). By independently optimizing each segment through targeted gene introduction and knockout strategies, the overall L-valine production efficiency is improved without requiring complete pathway reconstruction

Inventive Principle:
Principle #1Segmentation

2Productivity

If by-product synthesis pathways are active, then strain metabolism is balanced, but L-valine production is reduced due to metabolic flux diversion

Engineering Contradiction:
ImproveL-valine production rateVSAvoidby-product concentration
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent extracts and removes competing metabolic pathways by knocking out specific genes (budA for acetoin synthesis, budC and gldA for 2,3-butanediol synthesis, pta for acetate synthesis). This eliminates the diversion of metabolic flux toward by-products, concentrating carbon flow toward L-valine production and achieving higher purity and yield

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent converts the metabolic bottleneck at alpha-acetolactate (the precursor for both L-valine and by-products) into a benefit by introducing high-activity heterologous enzymes (alsS from Bacillus subtilis). This ensures sufficient precursor supply for L-valine synthesis while the subsequent pathway blockages prevent by-product formation, turning the branching point into a unidirectional flow toward the desired product

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The engineered strains achieve high yields and production intensities of L-valine, with yields up to 0.587 g/g and production rates up to 2.14 g/L/h, using simple fermentation media and cost-effective substrates.

Implementation Method 1

increasing the synthesis of α-acetolactate

Methodology Applied
Scientific EffectEnzymatic catalysis: Enzyme

Implementation Method 2

microbial fermentation technology

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentUS20260028652A1Method for constructing l-valine producing strain, l-valine producing strain and use thereof
Publication Date: 2026.01.29 SHANDONG UNIV
  • US20260028652A1 patent drawing

AI summary

The present invention provides a method for constructing an L-valine production strain, the L-valine production strain, and use thereof. According to the method for constructing the L-valine-producing strain, a 2,3-butanediol- or acetoin-producing strain is used as a starting strain, and genetic engineering modification is performed on the strain to improve the L-valine yield thereof. The present invention provides a new thought and way for efficient production of L-valine, and obtains a new production strain for efficiently producing L-valine. The L-valine-producing strain obtained in the present invention requires a simple culture medium and has low fermentation substrate and culture costs; meanwhile, the strain has a high L-valine yield and has a single product component easy to separate.